Welcome to the website of the Association for Immunotherapy of Cancer

The website "Cancer Immunotherapy (C-IMT)" represents an information and education platform to achieve three complementary targets:

The organization of annual meetings on cancer immunotherapy. These meetings should present an update on the fundamentals and the clinical aspects of cancer immunotherapy.
The creation of an Internet data base "clinical trials", accessible to physicians and interested public. The Web portal is designed to provide both groups of interest with:
- the possibility to easily search for current trials and
- the ability to establish contact with the respective investigators of clinical trials.
The set-up of a communication platform for scientists and clinicians devoted to Cancer Immunotherapy.

News

Accepted Abstracts

After completing the peer-review process under supervision of the Board of Directors of CIMT, we would like to inform you now about the accepted abstracts.

You find the list of accepted abstracts here

Dear colleagues, dear members,

Due to the great interest we would like to announce the re-scheduling of the abstract submission deadline to Friday, 28 March 2008. This will provide you the opportunity to submit late breaking abstracts to communicate the most recent clinical and scientific breakthroughs to participants.

Please do not forget to register - submission of abstract does not replace online registration.

Furthermore, we like to bring the preliminary program to your attention (see attachment). It's our pleasure to announce a MHC Multimer Flow Cytometry-workshop organized in collaboration with Beckman-Coulter. For more information, please visit our website (http://www.c-imt.org).

Information regarding our industry exhibition is also provided on the CIMT website.

Hope to see you in Mainz,

Sebastian Kreiter
(scientific secretary)

Publications

Krebsimmuntherapien

Standards und Innovationen
Deutscher Ärzteverlag
ISBN 978-3-7691-1212-2

Language of publication: German

Cancer Immunotherapy – New ways for the treatment of cancer

As co-operative effort of several members of the CIMT consortium a new book was recently published.
This is the first time that a book gives a comprehensive overview about:

The fundamental mechanisms and target structures suitable for cancer immunotherapy
The different modalities of cancer immunotherapy (antibody therapy, vaccination, allogenic stem cell transplantation, adoptive cell transfer)
Cancer immunotherapy in non-solid cancers (leukemia, lymphoma, multiple myeloma and myelodysplastic syndrome)
Cancer immunotherapy in solid cancers (Lung carcinoma, head and neck cancer, tumors of the gastro-intestinal tract, tumors of the skin, tumors in gynecology, tumors of the urogenital tracts, brain tumors)